MYRIAD GENETICS, INC. Available-for-sale Securities, Amortized Cost Basis
MYRIAD GENETICS, INC. (MYGN) had Available-for-sale Securities, Amortized Cost Basis of $192.10 million as of 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2018-11-07
- 2018-09-30: Available-for-sale Securities, Amortized Cost Basis $192.10M.
- 2018-06-30: Available-for-sale Securities, Amortized Cost Basis $211.90M.
- 2018-03-31: Available-for-sale Securities, Amortized Cost Basis $209.20M.
- 2017-12-31: Available-for-sale Securities, Amortized Cost Basis $202.40M.
| Period end | Available-for-sale Securities, Amortized Cost Basis | Available-for-sale Securities, Amortized Cost Basis as first filed |
|---|---|---|
| 2018-09-30 | $192.10M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $211.90M 10-Q · filed 2018-11-07 | |
| 2018-03-31 | $209.20M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $202.40M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $198.40M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $199.30M 10-K · filed 2018-08-24 | |
| 2017-03-31 | $225.60M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $218.30M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $200.40M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $238.40M 10-K · filed 2017-08-09 | |
| 2015-06-30 | $185.40M 10-K · filed 2015-08-12 | |
| 2015-03-31 | $175.55M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $229.47M 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $236.13M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $270.20M 10-K · filed 2015-08-12 | $270.22M 10-K · filed 2014-08-13 |
| 2014-03-31 | $277.38M 10-Q · filed 2014-05-07 | |
| 2013-06-30 | $531.50M 10-K · filed 2014-08-13 | |
| 2011-06-30 | $417.08M 10-K · filed 2011-08-15 | |
| 2010-06-30 | $488.16M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |